Kevin P. Daly |Medical Services
Specialities
Centers
Departments
Programs
Languages
- English
Kevin P. Daly |Education
Undergraduate School
Biochemical Sciences
Harvard University
2000, Boston, MA
Medical School
Columbia University College of Physicians & Surgeons
2004, New York, NY
Internship
Children’s Hospital at Montefiore
2005, Bronx, NY
Residency
Pediatrics
Children’s Hospital at Montefiore
2007, Bronx, NY
Fellowship
Pediatric Cardiology
Boston Children's Hospital
2009, Boston, MA
Fellowship
Chief Fellow, Pediatric Cardiology
Boston Children's Hospital
2010, Boston, MA
Fellowship
Pediatric Cardiology; Heart Failure; Transplantation Senior Fellow
Boston Children's Hospital
2011, Boston, MA
Kevin P. Daly |Professional History
I am a pediatric cardiologist at Boston Children’s Hospital specializing in Heart Failure & Transplantation. My clinical work is focused on the evaluation and management of children with advanced heart failure and those requiring mechanical circulatory support and/or heart transplantation. I am also a translational researcher focused on the development of biomarkers and novel imaging technologies which will allow for non-invasive diagnosis of cardiac allograft vasculopathy (CAV).
I am a clinical expert in the diagnosis and management of the highly sensitized pediatric heart transplant patient and those who develop antibody mediated rejection. I have published our center’s experience with peri-operative desensitization for crossmatch positive heart transplantation and utilized eculizumab (a terminal complement inhibitor) and bortezomib (a proteasome inhibitor) for the treatment of antibody mediated rejection. I am the only transplant physician in our group to perform intracardiac hemodynamics, endomyocardial biopsies, and coronary angiography in transplant patients and have expertise in the diagnosis of CAV.
我已经证明,VEGF-A可用于对心脏移植后儿童发育室的风险进行分层。我们正在计划一项前瞻性研究,以确定VEGF-A测试是否可以安全地减少小儿心脏移植受者中侵袭性冠状动脉造影手术的频率。此外,我正在领导多中心协作,以设计和执行小儿心脏移植中维持免疫抑制的首次随机控制试验。我们预计该试验将支持第一个FDA批准的儿科心脏移植中免疫抑制的指示。